simvastatin has been researched along with xanthine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Makita, S; Oshima, K; Wajima, T | 1 |
| Baillie, RA; Fiehn, O; Kaddurah-Daouk, R; Karp, PD; Krauss, RM; Trupp, M; Wikoff, WR; Zeng, ZB; Zhu, H | 1 |
1 trial(s) available for simvastatin and xanthine
| Article | Year |
|---|---|
Metabolomics reveals amino acids contribute to variation in response to simvastatin treatment.
Topics: Adult; alpha-Tocopherol; Amino Acids, Essential; Biomarkers, Pharmacological; Cholesterol, LDL; Citrulline; Cystine; Female; Fructose; Gas Chromatography-Mass Spectrometry; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lauric Acids; Male; Metabolomics; Nitric Oxide Synthase; Ornithine; Simvastatin; Stearic Acids; Succinic Acid; Xanthine | 2012 |
1 other study(ies) available for simvastatin and xanthine
| Article | Year |
|---|---|
Direct vascular effects of HR780, a novel 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor.
Topics: Animals; Aorta, Thoracic; Cell Division; Cell Movement; Cells, Cultured; Dose-Response Relationship, Drug; Endothelial Cells; Fetal Blood; Hydroxymethylglutaryl-CoA Reductase Inhibitors; L-Lactate Dehydrogenase; Male; Mevalonic Acid; Muscle, Smooth, Vascular; Platelet-Derived Growth Factor; Pravastatin; Probucol; Pyridines; Rabbits; Simvastatin; Swine; Xanthine; Xanthine Oxidase | 2003 |